STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
TCRR TCR2 THERAPEUTICS INCORPORATED StockScouter® Report
3
StockScouter® Score
TCR2 THERAPEUTICS INCORPORATED, a small cap company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Short-term relative price momentum exhibits moderate strength. Postive/Neutral
Concerns
- The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative
- Executives, board directors or major shareholders have both bought and sold shares recently. Neutral
- The multi-period measure of relative price change and consistency is average. Neutral
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be in favor, stocks will be , and healthcare stocks will be in favor.
Expected Risk/Return
Core Model Grades
D
C
N/A
C